FourThought Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$826K Buy
2,555
+52
+2% +$16.5K 0.12% 128
2022
Q2
$812K Hold
2,503
0.12% 130
2022
Q1
$717K Sell
2,503
-55
-2% -$14.2K 0.09% 150
2021
Q4
$707K Sell
2,558
-229
-8% -$58.1K 0.09% 156
2021
Q3
$643K Buy
2,787
+20
+0.7% +$4.94K 0.09% 169
2021
Q2
$635K Sell
2,767
-9
-0.3% -$1.81K 0.09% 180
2021
Q1
$518K Sell
2,776
-350
-11% -$68.5K 0.08% 207
2020
Q4
$527K Buy
+3,126
New +$467K 0.08% 183

Other funds holding LLY

FourThought Financial's LLY Position: Q3 2022 in Review

FourThought Financial increased its Eli Lilly (LLY) stake by 2.1% in Q3 2022, buying an estimated $16.5K and bringing the position to 2,555 shares worth $826K. The position accounts for 0.12% of the portfolio, ranked #128.

FourThought Financial first reported a position in LLY in Q4 2020 and has held it in 8 quarters since. 2,485 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • FourThought Financial held 2,555 shares of Eli Lilly worth $826K as of Q3 2022.
  • FourThought Financial bought 52 Eli Lilly shares in Q3 2022, an estimated $16.5K.
  • Eli Lilly made up 0.12% of FourThought Financial's portfolio in Q3 2022, its #128 holding.
  • FourThought Financial first reported a position in Eli Lilly in Q4 2020 and has held it in 8 quarters since.
  • 2,485 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.